NORGINE PHARMACEUTICALS LIMITED

1. NORGINE PHARMACEUTICALS LIMITED 2005-12-09 → present
2. NORGINE INTERNATIONAL LIMITED 2002-07-01 → 2005-12-09
3. NORGINE RESEARCH LIMITED 1998-03-13 → 2002-07-01

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Ernst & Young LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Company meets its day-to-day working capital requirements through the Group treasury function and its bank facilities. The Directors have also received a letter of support from an intermediary parent Company, Spinnaker Debtco Limited, and have made enquiries of the Directors of the parent Company to confirm that it has the ability to provide financial support. They have considered information regarding its ability to provide support to the Company including the Spinnaker Topco Limited Group Going Concern assessment, which includes covenant tests for Q3 2025 to Q3 2026 based on available financial forecasts which confirm that the banking covenants set out in the banking facilities agreements will be met. Based on this information, the Directors are confident that the Group will have sufficient funds to continue to meet its liabilities as they fall due up to 30th September 2026 and therefore have prepared the financial statements on a going concern basis.”

Significant events

• “There are no subsequent events.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

7

last 12 months

Capital events

0

last 24 months

Officers appointed

2

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +23.6%

  £56,334,000 → £69,609,000

• Cash

  -85.4%

  £11,344,000 → £1,657,000

• Net assets

  +8.2%

  £20,238,000 → £21,907,000

• Employees

  -32.7%

  49 → 33

• Operating profit

  +31.8%

  £1,741,000 → £2,294,000

• Profit before tax

  +10.1%

  £1,533,000 → £1,688,000

• Wages

  +4.9%

  £3,562,000 → £3,737,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers